Algeria – Increase of 13 % of drug importation bill

February 6, 2013 8:31 pm0 commentsViews: 156

NAlgerian pharmaceutical products importation bill reached $ 2.23 billion USD in 2012, a growth of 13.6% compared to 2011 (1.96 bn usd), said Algerian customs.

The volume of imports of pharmaceutical products has also recorded a boom of more than 45%, from 24 468 tons in 2011 to 35,540 tons, according to Algerian customs.

The domestic market of pharmaceutical products accounted for 2.9 billion USD in 2011, among which 1.85 billion USD for importation and 1.05 billion USD for local production where 84% goes to the private sector and 16% to the public, according to the National Union of pharmacy operators (UNOP).

The objective of Algeria is to produce 70% of its local drug needs with the help of foreign laboratories by the end of 2015. To achieve this goal, the government has taken important measures to establish a pharmaceutical industry able to provide effective coverage of the growing needs of the population, particularly by encouraging investment and industrial partnerships & joint-ventures.

In this context, a development plan was launched to increase the market share of the Public Pharmaceutical Group SAIDAL to pass from 7% to 25% in terms of value, to improve its position in the domestic market and grow internationally. With a financing of nearly 220 million USD , Saidal group will create seven new plants including three specialized plants in the production of generics drugs in the cities of Constantine, Tipasa and Algiers. The development plan also focuses on upgrading existing production plants, the creation of a R&D center in the new town of Sidi Abdallah and a laboratory for bioequivalence studies in Hussein Dey (Algiers).

[by Algeria Press Service]

Comment this Post

You must be logged in to post a comment.

Recent Comments